Delivery Order SPE2DR25D3301-SPE2DR26F18SL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $10,396.30, with an ultimate completion date of November 17, 2025. This is a non-set-aside competitive award issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a major healthcare solutions provider serving federal medical procurement needs. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,183.09 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed-price contract with a ceiling value of $1,183.20. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.84 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lidocaine 5% Patch 30S, a topical anesthetic medication commonly used for localized pain relief. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 18, 2025, with fulfillment through AmerisourceBergen's operations in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,363.52 for Lidocaine 5% Patch 30s, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.55 for Lidocaine 5% Patch 30s, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,722.08 for Lidocaine 5% Patch 30-count units, with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded a $16,391.49 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Lidocaine 5% Patch (30-count units). This firm fixed-price contract, with an ultimate completion date of November 14, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award utilized no set-aside designation, indicating competitive procurement. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $4,573.18. This is a firm fixed price delivery order with an ultimate completion date of November 17, 2025, representing a child order under AmerisourceBergen's larger contract vehicle. The award was made through open competition with no set-aside designation, and performance will be executed from the company's Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,587.42 for Lidocaine 5% Patch (30-count units) with a firm fixed price contract type. The award was made on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18SLDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,663.42 for Lidocaine 5% Patch (30-count units) with a firm fixed price structure. The order, issued on November 26, 2025, has an ultimate completion date of November 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. This non-competitive delivery order was executed without a set-aside designation and represents a routine pharmaceutical supply transaction within the federal medical procurement system. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government medical systems through this comprehensive global pharmaceutical support contract. The current award for topical pain management medication exemplifies the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to support military and federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 11/25/25 |